Effect of antibiotic pretreatment on resistance

Seminars in Respiratory Infections

Volumn 17, Issue 3, 2002, Pages 240-245

  Paradisi, Franco ^a   Corti, Giampaolo ^a   Sbaragli, Serena ^a   Benedetti, Marta ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; DOXYCYCLINE; ERYTHROMYCIN; OXYTETRACYCLINE; PENICILLIN DERIVATIVE; PIPERACILLIN; TAZOBACTAM;

ANTIBIOTIC RESISTANCE; DRUG EFFICACY; DRUG USE; ENTEROBACTERIACEAE; EPIDEMIOLOGICAL DATA; HAEMOPHILUS INFLUENZAE; INFECTION; MORAXELLA CATARRHALIS; NONHUMAN; PRESSURE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; STREPTOCOCCUS PNEUMONIA; VIRUS INFECTION;

ANTIBIOTIC PROPHYLAXIS; DRUG RESISTANCE, BACTERIAL; HUMANS; RESPIRATORY TRACT INFECTIONS;

EID: 0036736365     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2002.34688     Document Type: Review

References (33)

1. Lister PD: Emerging resistance problems among respiratory tract pathogens. Am J Manag Care 6:409-418, 2000 (suppl)
2. File TM: Emerging antimicrobial resistance on the eve of the new millennium. Hospital practice, a special report: Challenges in the management of antimicrobial-resistance pathogens. Minneapolis, McGraw-Hill, 1998
3. Acar JF, Goldstein FW: Consequences of increasing resistance to antimicrobial agents. Clin Infect Dis 27:125-130, 1998 (suppl)
4. Hand WL: Current challenges in antibiotic resistance. Adolesc Med 11:427-438, 2000
5. McGowan JE Jr: Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 5:1033-1048, 1983
6. Salyers AA, Amabile-Cuevas CF: Why are antibiotic resistance genes so resistant to elimination? Antimicrob Agents Chemother 11:2321-2335, 1997
7. Guillemot D: Antibiotic use in humans and bacterial resistance. Curr Opin Microbiol 2:494-498, 1999
8. Monnet DL: Antibiotic use and bacterial resistance. Ann Fr Anesth Reanim 19:409-417, 2000
9. Gonzales R, Steiner JF, Sande MA: Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 278:901-904, 1997
10. Bennett J, Geme JW: Bacterial resistance and antibiotic use in the emergence department. Pediatr Clin North Am 46: 1125-1143, 1999
11. Boken DJ, Chartrand SA, Goering RV, et al: Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center. Pediatr Infect Dis J 14:879-884, 1995
12. Kristinsson KG, Hjalmarsdottir MA, Gudnason TH: Continued decline in the incidence of penicillin nonsusceptible pneumococci in Iceland [abstract C-22]. Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998, pp 74-75
13. Seppälä H, Klaukka T, Vuopio-Varkila J, et al: The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med 337:441-446, 1997
14. Jacobson KL, Cohen SH, Inciardi JF, et al: The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I β-lactamaseproducing organisms. Clin Infect Dis 21:1107-1113, 1995
15. Pechère JC: Emergence of resistance in gram-negative bacilli during β-lactam therapy: A challenge for the future. Eur J Cancer 25:17-23, 1989 (suppl)
16. Örtqvistå: Antibiotic treatment of community-acquired pneumonia in clinical practice: A European perspective. J Antimicrob Chemother 35:205-212, 1995
17. Thornsberry C, Jones ME, Hickey ML, et al: Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998. J Antimicrob Chemother 44:749-759, 1999
18. Rice LB, Eckstein EC, DeVente J, et al: Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Administration Affairs Medical Center. Clin Infect Dis 23:118-124, 1996
19. Shlaes DM, Gerding DN, John JF Jr, et al: Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the prevention of antimicrobial resistance: Guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 25:584-599, 1997
20. Fridkin SK, Steward CD, Edwards JR, et al: Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Clin Infect Dis 29:245-252, 1999
21. Voss A, Milatovic D, Wallrauch-Schwarz C, et al: Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 13:50-55, 1994
22. Schentag JJ, Hyatt JM, Carr JR, et al: Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control. Clin Infect Dis 26:1204-1214, 1998
23. Girou E, Pujade G, Legrand P, et al: Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 27:543-550, 1998
24. Jacobs MR, Bajaksouzian S, Lin G, et al: Variation in antimicrobial resistance of community isolates of Streptococcus pneumoniae by age, region, and disease [abstract C-16]. Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998, p 73
25. Harwell JI, Brown RB: The drug resistance pneumococcus, clinical relevance, therapy, and prevention. Chest 117:530-541, 2000
26. Del Castillo F, Baquero-Artigao F, Garcia-Perea A: Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. Pediatr Infect Dis J 17:94-97, 1998
27. Block SL, Harrison CJ, Hedrick JA, et al: Penicillin-resistant Streptococcus pneumoniae in acute otitis media: Risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 14:751-759, 1995
28. Schwartz B, Bell DM, Hughes JM: Preventing the emergence of antimicrobial resistance: A call for action by clinicians, public health officials, and patients. JAMA 278:944-945, 1997
29. Chow JW, Fine MJ, Shales DM, et al: Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115:585-590, 1991
30. Dworzak DL, Pugsley MP, Sanders CC, at al: Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins. Eur J Clin Microbiol 6: 456-459, 1987
31. Cohen SH, King JH, Morita MM, et al: The relationship between Enterobacter isolates resistant to extended spectrum cephalosporins and antecedent antibiotic use [abstract 654]. Program and Abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, TX, 1989
32. Mouton JW: Combination therapy as a tool to prevent emergence of bacterial resistance. Infection 27:24-28, 1999 (suppl)
33. Korinek AM: Ecological consequences of preventive antibiotic prescriptions. Ann Fr Anesth Reanim 19:418-423, 2000